TSX open
Loading markets…

Advertisement

Stocks

Why Hemostemix Inc stock is plummeting today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:HEM.V

Get HEM alerts:

Photos provided by Pexels

Hemostemix Inc. is facing significant losses in the market, with its stock price falling sharply.

Hemostemix Inc. (HEM.V) is experiencing a notable decline, with shares dropping by 7.14% in today's trading session. The stock closed at CA$0.07, reflecting investor concerns amid a lack of substantial news to support the company's valuation.

Advertisement

Hemostemix Inc

HEM.V

Full stock page →

HEM.V

Hemostemix Inc

Source:WealthAwesomeWealthAwesome
$0.02 (-26.32%)
120 day period
$0.04$0.07$0.10Jan 22Apr 28Aug 13

Advertisement

Market cap

$14.35M

52W high

$0.14

52W low

$0.04

1W change

+7.69%

Beta

0.61

Analyst Price Targets

Based on analyst covering HEM

📈

Wall Street analysts forecast HEM stock price to rise 1271.4% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.96

+1271.4% Upside

Current Price

C$0.07

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Advertisement

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HEM's historical volatility

HistoricalForecast68%95%
C$0.01C$0.09C$0.16C$0.23C$0.31C$0.38TodayMar 6May 21Aug 13Sep 25Nov 8Dec 21

30-Day Vol

139.0%

Annualized

90-Day Vol

116.4%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.07

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.07C$0.04C$0.11
60 trading daysC$0.07C$0.04C$0.14
90 trading daysC$0.07C$0.03C$0.16

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: Investors should remain cautious with Hemostemix Inc. as the stock's recent performance suggests underlying weaknesses that could impact future growth.

Hemostemix Inc. shares drop 7.14% today

The company's market cap now stands at approximately CA$13.3 million, raising questions about its financial stability and growth potential.

Bull case

Despite today's setback, Hemostemix has been actively raising capital through private placements. This funding could be crucial for its ongoing projects and operational expenses, helping the company stay afloat during tough times.

Bear case

The sharp decline in stock price indicates potential investor skepticism about the company's prospects. With a low market cap and no recent positive news, many are questioning whether Hemostemix can turn things around.

Market Reaction

Advertisement

The market reaction to Hemostemix Inc.'s stock performance today reflects a growing concern among investors. The 7.14% drop raises questions about the company's future, especially given its low market cap of CA$13.3 million. Without significant news or developments, investor confidence appears to be waning.

Funding Efforts

Hemostemix has been actively engaging in private placements to raise capital, which is crucial for its ongoing projects and operational costs. The recent closures of multiple private placements, including a CDN$360,000 tranche, show that the company is trying to improve its financial position. However, the effectiveness of these efforts remains uncertain as the stock continues to struggle.

Looking Ahead

As Hemostemix Inc. navigates this challenging period, investors should keep a close eye on any forthcoming news or developments. The company's ability to leverage its recent funding for growth initiatives will be critical in restoring investor confidence and stabilizing its stock price.


Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 14, 2026
Last Updated: August 14, 2026

Sponsored links

Advertisement